$26.850
+0.615 (+2.29%)終値時点
価格予想
アプリで開くと、より長期の予想を確認できます。
Apnimed Inc 株は買うべき？
Apnimed, Inc. is a good buy right now due to its strong recent performance, with a year-to-date change of +85.69% and a positive analyst outlook, including a target price of $60 from Cantor Fitzgerald. The upcoming FDA decision for its lead product, Oxnimbi, on February 28, 2027, adds a significant potential catalyst for growth. However, the main risk is the regulatory scrutiny associated with the FDA approval process, which could impact the stock negatively.
APMD の株価は Tuesday に $26.85 で引け、その前に上昇 +2.29%
Apnimed Inc (APMD) last closed at $26.85, gaining +2.29%. These facts feed the 1-day and 1-week APMD price prediction above.
予想の要因
Apnimed Inc（APMD）の予想は、類似したチャートパターン・季節性・移動平均を組み合わせています。
Seasonality
Bullish
APMD の季節性分析
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。